ArticleJournal of human genetics2024

CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer's disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion.

Yuya Asanomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.